ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Daewoong Pharmaceutical Publishes Results of First Clinical Study of SGLT-2 Inhibitor 'Enavogliflozin' for Canine Diabetes
June 02, 2021Daewoong Pharmaceutical (CEO Sengho Jeon) announced that the results of an investigator-initiated clinical study on the effect of Enavogliflozin, originally developed as Type II Diabetes Treatment for humans, on treating canine diabetes were published ...
Pharma Sources Insight January 2025
